The Evolving Strategy of Californium-252 Neutron Intracavitary Brachytherapy in Treating Patients With Low-Lying T2 or T3 Rectal Adenocarcinoma: From Fixed to Individualized Regime With Intrarectal Peritumoral Injection of Amifostine

The Evolving Strategy of Californium-252 Neutron Intracavitary Brachytherapy in Treating Patients With Low-Lying T2 or T3 Rectal Adenocarcinoma: From Fixed to Individualized Regime With Intrarectal Peritumoral Injection of Amifostine

PurposeTo retrospectively and comparatively evaluate the improvement of the efficacy and safety on the addition of 252Cf neutron intracavitary brachytherapy (ICBT), individualized or individualized with intrarectal peritumoral injection of amifostine (IPIA) to external-beam radiotherapy (EBRT) or co...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yanli Xiong, Li Shao, Jia Liu, Qian Zhou, Chongyi Li, Maojun Liao, Lei Zhang, Xiaoyan Dai, Mengxia Li, Xin Lei
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
rectal adenocarcinoma
radiotherapy
252Cf neutron
brachytherapy
sphincter preservation
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Accès en ligne:https://doaj.org/article/d091d478b26c4be785f2c505342103a9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/d091d478b26c4be785f2c505342103a9

Documents similaires